WhiteOak Capital Pharma and Heathcare Fund Regular Plan Growth
₹14.9550
₹0.11 (-0.73%)
NAV as of 29 May 2026
Today's NAV — all variants
Regular · Growth
₹₹14.9550
₹0.11 (-0.73%)
29 May 2026
AMFI: 152348
Direct · Growth
₹₹15.5690
₹0.11 (-0.72%)
29 May 2026
AMFI: 152349
Returns (Lumpsum)
CAGR for periods ≥ 1 yearSIP Returns (XIRR)
₹1,000/month SIP, annualisedSIP since inception — what ₹100/month became
Real NAV backtest from day one
₹2,800
Invested
₹3,395
Value today
16.9%
XIRR (p.a.)
₹100/month SIP from fund inception · Current value as of today
Try SIP Calculator with this fund's history₹500 lumpsum at launch — value today
Invested on the fund's first NAV date
₹500
Invested
₹753
Value today
19.0%
CAGR (p.a.)
One-time investment at fund inception · Growth purely from NAV appreciation
Try Lumpsum Calculator₹6L corpus via 12-month STP from a liquid fund at inception
₹50K/month transferred from HDFC Liquid → this fund at launch
₹6,00,000
Invested
₹8,21,062
Value today
-9.2%
vs lumpsum
Direct lumpsum would have beaten STP by 9.2% — but STP reduced timing risk
Model your own STP with real NAVBeat the benchmark — ₹100/month SIP
Same SIP in this fund vs the benchmark index
This fund
₹3,395
Benchmark
₹2,876
+₹519 extra wealth vs the benchmark index
Backtest this SIP yourselfDirect vs Regular — ₹500/month over 2 years
Expense ratio drag on your actual returns
Direct plan
₹15,011
Regular plan
₹14,725
Direct earns ₹286 more on a ₹12K investment — 1.19% extra return per year
Same fund, same NAV history — only the expense ratio differs. Direct plans always outperform Regular over time.
Learn about Direct vs Regular plansFund Details
Risk Metrics
Trailing 1 year, annualised0.28
Sharpe Ratio
+0.10
Alpha
0.37
Beta
0.26
Sortino
15.42%
Std Dev
-15.62%
Max Drawdown
Portfolio Holdings
Performance Comparison
Interested in This Fund?
Our experts will help you decide if this fund fits your goals.
Compare with Similar Funds
Investment Objective
WhiteOak Capital Pharma and Heathcare Fund Regular Plan Growth invests in stocks from a specific sector or theme, offering concentrated exposure to a particular area of the economy. These funds carry sector-specific risks but can deliver significant returns when the underlying sector performs well.
About This Fund
WhiteOak Capital Pharma and Heathcare Fund Regular Plan Growth is a Sectoral / Thematic mutual fund offered by WhiteOak Capital Mutual Fund. The fund has been operational for over 2 years. It manages assets worth ₹524 Cr, reflecting investor confidence in the fund's strategy. It benchmarks its performance against NIFTY 500 TRI. The current expense ratio is 2.37%.
Who Should Invest?
- •Investors with a high risk appetite seeking long-term wealth creation
- •Investors with an investment horizon of 5 years or more
- •SIP investors who can benefit from rupee cost averaging during market fluctuations